In contrast, PD-L1 expression had moderate potential (0.9 > AUC > 0.7) to predict immune scores in most cancer types, while glycolysis score, TMB and MSI performed poorly in predicting immune score accuracy (AUC, 0.45–0.75; Fig. 3A, Supplementary Table 3). This evidence concerns the gene CD274 and cancer.